Ethic Inc. increased its position in shares of Axon Enterprise, Inc (NASDAQ:AXON – Free Report) by 9,571.5% in the 3rd quarter, Holdings Channel.com reports. The institutional investor owned 618,108 shares of the biotechnology company’s stock after buying an additional 611,717 shares during the quarter. Axon Enterprise makes up 2.9% of Ethic Inc.’s investment portfolio, making the stock its 4th largest holding. Ethic Inc.’s holdings in Axon Enterprise were worth $261,163,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also bought and sold shares of the company. M & L Capital Management Ltd bought a new position in Axon Enterprise in the 3rd quarter worth $30,000. Keating Financial Advisory Services Inc. acquired a new position in Axon Enterprise during the 2nd quarter worth $31,000. Wealth Enhancement Trust Services Inc. bought a new stake in Axon Enterprise during the third quarter valued at about $33,000. Putney Financial Group LLC bought a new stake in Axon Enterprise during the third quarter valued at about $36,000. Finally, Washington Trust Advisors Inc. boosted its holdings in Axon Enterprise by 1,300.0% during the second quarter. Washington Trust Advisors Inc. now owns 70 shares of the biotechnology company’s stock valued at $39,000 after acquiring an additional 65 shares during the period. 79.08% of the stock is currently owned by institutional investors and hedge funds.
Wall Street Analysts Forecast Growth
Several equities research analysts have recently issued reports on the company. Needham & Company LLC lowered their price target on Axon Enterprise from $750.00 to $500.00 and set a “buy” rating on the stock in a research report on Friday. Weiss Ratings reissued a “hold (c-)” rating on shares of Axon Enterprise in a research report on Tuesday. Royal Bank Of Canada cut their price objective on Axon Enterprise from $735.00 to $615.00 and set an “outperform” rating for the company in a research report on Friday. Morgan Stanley increased their target price on Axon Enterprise from $600.00 to $640.00 and gave the company an “overweight” rating in a research note on Thursday, August 6th. Finally, Northcoast Research raised their target price on Axon Enterprise from $650.00 to $680.00 and gave the company a “buy” rating in a report on Tuesday, August 11th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $631.35.
Insider Transactions at Axon Enterprise
In other Axon Enterprise news, CEO Patrick W. Smith sold 10,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the sale, the chief executive officer owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This trade represents a 0.32% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Joshua Isner sold 16,775 shares of Axon Enterprise stock in a transaction that occurred on Monday, August 31st. The stock was sold at an average price of $574.43, for a total value of $9,636,063.25. Following the sale, the president directly owned 296,974 shares in the company, valued at $170,590,774.82. The trade was a 5.35% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 37,397 shares of company stock valued at $21,234,034. 4.20% of the stock is currently owned by insiders.
Axon Enterprise News Summary
Here are the key news stories impacting Axon Enterprise this week:
- Positive Sentiment: Q3 revenue reached a record $909 million, up 28% year over year, while software and services revenue rose 43%. Axon also reported AI annual recurring revenue above $100 million, signaling continued demand for its software and AI offerings. Axon Q3 results
- Neutral Sentiment: Axon committed an additional $1.2 billion to drone maker Skydio, bringing its stake to 37% and making it Skydio’s exclusive public-safety distributor in the U.S. and Canada. The move could expand Axon’s Drone as First Responder business, but its scale also raises investment and execution risks. Reuters: Axon invests in Skydio
- Negative Sentiment: Q3 adjusted earnings of $1.72 per share and revenue of $908.55 million fell short of analyst expectations. Axon’s 2026 revenue forecast was reduced to $3.6 billion from a consensus of about $3.7 billion; its Q4 revenue guidance also came in below estimates. The company cited delays in federal counter-drone projects, while margin pressure added to concerns. Zacks: Q3 miss and outlook
- Negative Sentiment: Several analysts lowered price targets after the results, and Craig Hallum downgraded AXON from Buy to Hold, adding to pressure on investor sentiment. Benzinga: analyst forecast changes
- Negative Sentiment: A class-action lawsuit over Axon’s license-plate surveillance practices is a potential additional legal and reputational overhang. Class-action announcement
Axon Enterprise Stock Performance
NASDAQ:AXON opened at $313.00 on Friday. The firm’s 50-day moving average is $441.53 and its 200-day moving average is $475.20. The company has a market cap of $25.43 billion, a price-to-earnings ratio of 100.32, a PEG ratio of 5.95 and a beta of 1.48. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15. Axon Enterprise, Inc has a 52-week low of $307.00 and a 52-week high of $665.07.
Axon Enterprise (NASDAQ:AXON – Get Free Report) last released its earnings results on Thursday, November 5th. The biotechnology company reported $1.72 earnings per share for the quarter, missing the consensus estimate of $1.89 by ($0.17). Axon Enterprise had a net margin of 7.56% and a return on equity of 3.95%. The company had revenue of $908.55 million during the quarter, compared to the consensus estimate of $934.33 million. During the same quarter in the previous year, the business posted $1.17 EPS. The firm’s quarterly revenue was up 27.8% on a year-over-year basis. Equities research analysts anticipate that Axon Enterprise, Inc will post 2.10 earnings per share for the current year.
Axon Enterprise Profile
Axon Enterprise develops technology and services for public safety agencies. Its products include TASER conducted-energy weapons, body-worn and in-car cameras, and related hardware designed to support law enforcement and other safety professionals.
The company also provides cloud-based software for managing digital evidence, records and operational workflows. Its Axon Evidence platform helps agencies store, organize and share video and other evidence, while its broader software offerings include tools for dispatch and records management.
Founded in 1993 as TASER International, the company adopted the name Axon Enterprise in 2017 as it expanded beyond conducted-energy weapons into connected devices and software.
Featured Articles
- Five stocks we like better than Axon Enterprise
- Dutch Bros Gave Wall Street What It Wanted, So Why Did the Stock Crater?
- Astera Labs Just Crushed Earnings—So Why Are Analysts Cutting Price Targets?
- Sandisk Shares Are Oversold: Bargain or Value Trap?
- IonQ’s Record Revenue Includes a Big SkyWater Boost: Does That Change the Story?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
